122 related articles for article (PubMed ID: 8304117)
1. An example of the detection of an esophageal carcinoma in its very early stage by urinary xanthopterin determination.
Iino T; Watanabe H; Gyure WL; Mazda T; Mieno H; Tsusué M
Adv Exp Med Biol; 1993; 338():243-6. PubMed ID: 8304117
[No Abstract] [Full Text] [Related]
2. Pretreatment levels of CEA, CA 19-9, CA 50 and CA 72-4 in sera of patients with squamous cell carcinoma of the oesophagus.
Rakic S; Kalezic V; Grujic-Adanja G; Jagodic M
Eur J Cancer Prev; 1993 Jul; 2(4):361. PubMed ID: 8358290
[No Abstract] [Full Text] [Related]
3. Tumour marker detection in oesophageal carcinoma.
Mealy K; Feely J; Reid I; McSweeney J; Walsh T; Hennessy TP
Eur J Surg Oncol; 1996 Oct; 22(5):505-7. PubMed ID: 8903494
[TBL] [Abstract][Full Text] [Related]
4. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.
Kosugi S; Nishimaki T; Kanda T; Nakagawa S; Ohashi M; Hatakeyama K
World J Surg; 2004 Jul; 28(7):680-5. PubMed ID: 15383868
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
[TBL] [Abstract][Full Text] [Related]
7. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
8. SCC antigen in patients with esophageal cancer.
Fernández-Llamaazares J; Encabo G; Piñol M; Gelonch J
Int J Biol Markers; 1992; 7(4):267. PubMed ID: 1491186
[No Abstract] [Full Text] [Related]
9. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
10. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
Chen CG; Cui L; Tang P; Yu ZT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma of the endometrium presenting as peritonitis with small bowel obstruction.
Adelson MD; Strumpf KB
Gynecol Oncol; 1992 May; 45(2):214-8. PubMed ID: 1592291
[TBL] [Abstract][Full Text] [Related]
14. Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthopterin, and pterin.
Rokos H; Rokos K; Frisius H; Kirstaedter HJ
Clin Chim Acta; 1980 Aug; 105(2):275-86. PubMed ID: 7398095
[TBL] [Abstract][Full Text] [Related]
15. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
Brockmann JG; St Nottberg H; Glodny B; Sprakel B; Senninger N
Anticancer Res; 2000; 20(6D):4899-904. PubMed ID: 11332443
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
[TBL] [Abstract][Full Text] [Related]
17. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers.
Shimada H; Nakajima K; Ochiai T; Koide Y; Okazumi SI; Matsubara H; Takeda A; Miyazawa Y; Arima M; Isono K
Oncol Rep; 1998; 5(4):871-4. PubMed ID: 9625835
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma.
Quillien V; Raoul JL; Laurent JF; Meunier B; Le Prise E
Oncol Rep; 1998; 5(6):1561-5. PubMed ID: 9769406
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood.
Koike M; Hibi K; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2002 Sep; 8(9):2879-82. PubMed ID: 12231531
[TBL] [Abstract][Full Text] [Related]
20. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
